
This study evaluated the use of mechanical circulatory support (MCS) for non‐ischemic cardiogenic shock (CS). In this multicenter, international, retrospective study, data from 890 patients with non-ischemic CS, defined as CS due to severe de-novo or acute-on‐chronic heart failure with no need for urgent revascularization, were collected. MCS was used in 386 (43%) patients, and in patients with non‐ischemic CS, MCS use was associated with lower 30-day mortality as compared to medical therapy only, but also with more complications. Randomized trials are needed to validate these findings.
Like
Save
Share